Matthew Diaz | Senior Managing Director | FTI Consulting
Search Our People
Matt Diaz

Matthew Diaz

  • Senior Managing Director
  • Corporate Finance
  • T: +1 212 499 3611
  • F: +1 212 841 9350
Connect with Me:
Office
    • Three Times Square
    • 9th Floor
    • New York, NY, 10036
    • United States
    • T: +1 212 247 1010
    • F: +1 212 841 9350
Education
Certifications
Associations
Expertise
Industries

Matthew Diaz specializes in providing restructuring services to creditors in Chapter 11 and out-of-court special situations. He has industry expertise in diversified industrials, energy, power and products, mass tort, and retail and consumer products.

Mr. Diaz’s responsibilities have included the preparation and critical evaluation of plans of reorganization, financial projections, models and liquidation analyses; the assessment of asset sale proposals, key employee retention plans, financing facilities, disclosure statements, critical vendor programs and proceeds from litigation; and the analysis of creditor recoveries under various restructuring and financial scenarios.

Chapter 11 and out-of-court cases that Mr. Diaz has been involved in include Abengoa Bioenergy, Alliance Bancorp, Bally’s Total Fitness, Barnes Bay Development, Bear Island, Bestwall, Blitz, Bondex, Buehler Foods, Buffets, Calpine, Cengage Learning, Centaur, Chemtura, Colt, DBMP, Easy Gardener, Energy Future Holdings, Friendly’s Restaurants, Gander Mountain, Glass Group, Hawker Beechcraft, iHeartMedia, JC Penney, Kidspeace, Kimball Hill, Lionel, Metro Fuel, Mmodal, Mortgage Lenders Network, Northwest Airlines, Paddock, Payless, Penn Virginia Corporation, Pharmaceutical Formulations, Ponderosa Pine Energy Partners, Purdue Pharma, Samson Resources, Sears, Signature Styles, Smurfit Stone Container, TerreStar, Toys R Us, USA Discounters and Visteon.

Prior to joining FTI Consulting, Mr. Diaz served as Chief Financial Officer for Graham Field Health Products, a $100 million manufacturer operating in Chapter 11, and as Restructuring Director for Impath, a $150 million cancer diagnostic testing company operating in Chapter 11. At Graham Field, he successfully managed liquidity, obtained replacement debtor-in-possession financing and bridged the company to a sale. 

At Impath, Mr. Diaz reorganized the accounting and finance department after the departure of key personnel upon identification of accounting irregularities, led a reconstruction team that restated the current financial statements in less than four months, obtained a clean opinion from outside auditors and satisfied historical financial statement requirements for the buyers.

More Info

Share this page